|
1
|
National Lung Screening Trial Research
Team, . Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM,
Galen B, Gareen IF, Gatsonis C, Goldin J, et al: The National Lung
Screening Trial: Overview and study design. Radiology. 258:243–253.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Asamura H, Goya T, Koshiishi Y, Sohara Y,
Eguchi K, Mori M, Nakanishi Y, Tsuchiya R, Shimokata K, Inoue H, et
al: A Japanese Lung Cancer Registry study: Prognosis of 13,010
resected lung cancers. J Thorac Oncol. 3:46–52. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aberle DR, DeMello S, Berg CD, Black WC,
Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF,
et al: Results of the two incidence screenings in the National Lung
Screening Trial. N Engl J Med. 369:920–931. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu L, Zhao E, Li C, Huang L, Xiao L,
Cheng L, Huang X, Song Y and Xu D: TRIM28, a new molecular marker
predicting metastasis and survival in early-stage non-small cell
lung cancer. Cancer Epidemiol. 37:71–78. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Messerschmidt DM, de Vries W, Ito M,
Solter D, Ferguson-Smith A and Knowles BB: Trim28 is required for
epigenetic stability during mouse oocyte to embryo transition.
Science. 335:1499–1502. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Barde I, Rauwel B, Marin-Florez RM,
Corsinotti A, Laurenti E, Verp S, Offner S, Marquis J, Kapopoulou
A, Vanicek J and Trono D: A KRAB/KAP1-miRNA cascade regulates
erythropoiesis through stage-specific control of mitophagy.
Science. 340:350–353. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pfeifer GP: Protein phosphatase PP4: Role
in dephosphorylation of KAP1 and DNA strand break repair. Cell
Cycle. 11:2590–2591. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
White DE, Negorev D, Peng H, Ivanov AV,
Maul GG and Rauscher FJ III: KAP1, a novel substrate for PIKK
family members, colocalizes with numerous damage response factors
at DNA lesions. Cancer Res. 66:11594–11599. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gilmore-Hebert M, Ramabhadran R and Stern
DF: Interactions of ErbB4 and Kap1 connect the growth factor and
DNA damage response pathways. Mol Cancer Res. 8:1388–1398. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu C, Zhang S, Gao X, Gao X, Xu X, Lv Y,
Zhang Y, Zhu Z, Zhang C, Li Q, et al: Roles of kruppel-associated
box (KRAB)-associated co-repressor KAP1 ser-473 phosphorylation in
DNA damage response. J Biol Chem. 287:18937–18952. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin LF, Li CF, Wang WJ, Yang WM, Wang DD,
Chang WC, Lee WH and Wang JM: Loss of ZBRK1 contributes to the
increase of KAP1 and promotes KAP1-mediated metastasis and invasion
in cervical cancer. PLoS One. 8:e730332013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Addison JB, Koontz C, Fugett JH, Creighton
CJ, Chen D, Farrugia MK, Padon RR, Voronkova MA, McLaughlin SL,
Livengood RH, et al: KAP1 promotes proliferation and metastatic
progression of breast cancer cells. Cancer Res. 75:344–355. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fitzgerald S, Sheehan KM, O'Grady A, Kenny
D, O'Kennedy R, Kay EW and Kijanka GS: Relationship between
epithelial and stromal TRIM28 expression predicts survival in
colorectal cancer patients. J Gastroenterol Hepatol. 28:967–974.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yokoe T, Toiyama Y, Okugawa Y, Tanaka K,
Ohi M, Inoue Y, Mohri Y, Miki C and Kusunoki M: KAP1 is associated
with peritoneal carcinomatosis in gastric cancer. Ann Surg Oncol.
17:821–828. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang L, Zhu C, Guo Y, Wei F, Lu J, Qin J,
Banerjee S, Wang J, Shang H, Verma SC, et al: Inhibition of KAP1
enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus
reactivation through RBP-Jκ. J Virol. 88:6873–6884. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cui Y, Yang S, Fu X, Feng J, Xu S and Ying
G: High levels of KAP1 expression are associated with aggressive
clinical features in ovarian cancer. Int J Mol Sci. 16:363–377.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu M, Fu X, Cui Y, Xu S, Xu Y, Dong Q and
Sun L: Expression of KAP1 in epithelial ovarian cancer and its
correlation with drug-resistance. Int J Clin Exp Med.
8:17308–17320. 2015.PubMed/NCBI
|
|
19
|
Chen L, Muñoz-Antonia T and Cress WD:
Trim28 contributes to EMT via regulation of E-cadherin and
N-cadherin in lung cancer cell lines. PLoS One. 9:e1010402014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Czerwińska P, Shah PK, Tomczak K, Klimczak
M, Mazurek S, Sozańska B, Biecek P, Korski K, Filas V, Mackiewicz
A, et al: TRIM28 multi-domain protein regulates cancer stem cell
population in breast tumor development. Oncotarget. 8:863–882.
2017.PubMed/NCBI
|
|
21
|
Du ZY, Shi MH, Ji CH and Yu Y: Serum
pleiotrophin could be an early indicator for diagnosis and
prognosis of non-small cell lung cancer. Asian Pac J Cancer Prev.
16:1421–1425. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Halvorsen AR, Bjaanæs M, LeBlanc M, Holm
AM, Bolstad N, Rubio L, Peñalver JC, Cervera J, Mojarrieta JC,
López-Guerrero JA, et al: A unique set of 6 circulating microRNAs
for early detection of non-small cell lung cancer. Oncotarget.
7:37250–37259. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tas F, Bilgin E, Tastekin D, Erturk K and
Duranyildiz D: Clinical significance of serum laminin levels in
patients with lung cancer. Biomed Rep. 4:485–488. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun M, Song J, Zhou Z, Zhu R, Jin H, Ji Y,
Lu Q and Ju H: Comparison of serum microRNA21 and tumor markers in
diagnosis of early non-small cell lung cancer. Dis Markers.
2016:38231212016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sreseli RT, Binder H, Kuhn M, Digel W,
Veelken H, Sienel W, Passlick B, Schumacher M, Martens UM and
Zimmermann S: Identification of a 17-protein signature in the serum
of lung cancer patients. Oncol Rep. 24:263–270. 2010.PubMed/NCBI
|
|
26
|
Liu L, Xiao L, Liang X, Chen L, Cheng L,
Zhang L, Wu X, Xu Q and Ma C: TRIM28 knock-down increases
sensitivity to etoposide by upregulating E2F1 in non-small cell
lung cancer. Oncol Rep. 37:3597–3605. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bojkowska K, Aloisio F, Cassano M,
Kapopoulou A, de Sio Santoni F, Zangger N, Offner S, Cartoni C,
Thomas C, Quenneville S, et al: Liver-specific ablation of
Krüppel-associated box-associated protein 1 in mice leads to
male-predominant hepatosteatosis and development of liver adenoma.
Hepatology. 56:1279–1290. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang C, Ivanov A, Chen L, Fredericks WJ,
Seto E, Rauscher FJ III and Chen J: MDM2 interaction with nuclear
corepressor KAP1 contributes to p53 inactivation. EMBO J.
24:3279–3290. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang C, Rauscher FJ III, Cress WD and Chen
J: Regulation of E2F1 function by the nuclear corepressor KAP1. J
Biol Chem. 282:29902–29909. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kamitani S, Ohbayashi N, Ikeda O, Togi S,
Muromoto R, Sekine Y, Ohta K, Ishiyama H and Matsuda T: KAP1
regulates type I interferon/STAT1-mediated IRF-1 gene expression.
Biochem Biophys Res Commun. 370:366–370. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tsuruma R, Ohbayashi N, Kamitani S, Ikeda
O, Sato N, Muromoto R, Sekine Y, Oritani K and Matsuda T: Physical
and functional interactions between STAT3 and KAP1. Oncogene.
27:3054–3059. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rashidi B, Yang M, Jiang P, Baranov E, An
Z, Wang X, Moossa AR and Hoffman RM: A highly metastatic Lewis lung
carcinoma orthotopic green fluorescent protein model. Clin Exp
Metastasis. 18:57–60. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rashidi B, Moossa AR and Hoffman RM:
Specific route mapping visualized with GFP of single-file streaming
contralateral and systemic metastasis of Lewis lung carcinoma cells
beginning within hours of orthotopic implantation [correction of
implantion]. J Cell Biochem. 114:1738–1743. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yano S, Zhang Y, Miwa S, Kishimoto H,
Urata Y, Bouvet M, Kagawa S, Fujiwara T and Hoffman RM: Precise
navigation surgery of tumours in the lung in mouse models enabled
by in situ fluorescence labelling with a killer-reporter
adenovirus. BMJ Open Respir Res. 2:e0000962015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang Y, Jiang J, Li Q, Ma H, Xu Z and Gao
Y: KAP1 is overexpressed in hepatocellular carcinoma and its
clinical significance. Int J Clin Oncol. 21:927–933. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang YY, Li L, Zhao ZS and Wang HJ:
Clinical utility of measuring expression levels of KAP1, TIMP1 and
STC2 in peripheral blood of patients with gastric cancer. World J
Surg Oncol. 11:812013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hector S, Chen H, Kijanka G, Murray F and
Prehn JH: A reverse-ELISA for the detection of TRIM28/KAP1 serum
autoantibodies in colorectal cancer patients. Acta Oncol.
51:394–396. 2012. View Article : Google Scholar : PubMed/NCBI
|
